Abstract
The localized activation of coagulation in vascular malformations can lead to a consumptive coagulopathy characterized by elevated D-dimers and a consumption of fibrinogen and platelets, eventually giving rise to a bleeding tendency. By reducing coagulation activation, anticoagulant treatment with heparin is able to limit this haemostatic dysregulation and the associated bleeding diathesis. Here, we present a case of a consumptive coagulopathy due to a large venous malformation with a sustained correction of the fibrinogen depletion and associated bleeding tendency both with subcutaneous enoxaparin and with the oral factor Xa inhibitor rivaroxaban.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11239-013-1024-7/MediaObjects/11239_2013_1024_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11239-013-1024-7/MediaObjects/11239_2013_1024_Fig2_HTML.jpg)
References
Hermans C, Dessomme B, Lambert C, Deneys V (2006) Venous malformations and coagulopathy. Ann Chir Plast Esthet 51(4–5):388–393. doi:10.1016/j.anplas.2006.07.009
Martin LK, Russell S, Wargon O (2009) Chronic localized intravascular coagulation complicating multifocal venous malformations. Aus J Dermatol 50(4):276–280. doi:10.1111/j.1440-0960.2009.00558.x
Dompmartin A, Acher A, Thibon P, Tourbach S, Hermans C, Deneys V, Pocock B, Lequerrec A, Labbe D, Barrellier MT, Vanwijck R, Vikkula M, Boon LM (2008) Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol 144(7):873–877. doi:10.1001/archderm.144.7.873
Mazoyer E, Enjolras O, Laurian C, Houdart E, Drouet L (2002) Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach–Merritt syndrome. Clin Lab Haematol 24(4):243–251
Mazoyer E, Enjolras O, Bisdorff A, Perdu J, Wassef M, Drouet L (2008) Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients. Arch Dermatol 144(7):861–867. doi:10.1001/archderm.144.7.861
Enjolras O, Ciabrini D, Mazoyer E, Laurian C, Herbreteau D (1997) Extensive pure venous malformations in the upper or lower limb: a review of 27 cases. J Am Acad Dermatol 36(2 Pt 1):219–225
Scola M, Brophy M, Fiore L (2001) Localized consumptive coagulopathy. Circulation 104(1):120–121
Garzon MC, Huang JT, Enjolras O, Frieden IJ (2007) Vascular malformations. Part II: associated syndromes. J Am Acad Dermatol 56(4):541–564. doi:10.1016/j.jaad.2006.05.066
Bick RL (1981) Hereditary hemorrhagic telangiectasia and disseminated intravascular coagulation: a new clinical syndrome. Ann N Y Acad Sci 370:851–854
Verstraete M, Amery A, Vermylen C, Robyn G (1963) Heparin treatment of bleeding. Lancet 1(7278):446
Feinstein DI (1982) Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy. Blood 60(2):284–287
Jelenska MM, Szmidt J, Bojakowski K, Grzela T, Palester-Chlebowczyk M (2004) Compensated activation of coagulation in patients with abdominal aortic aneurysm: effects of heparin treatment prior to elective surgery. Thromb Haemost 92(5):997–1002. doi:10.1267/THRO04050997
Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. New Engl J Med 365(10):883–891. doi:10.1056/NEJMoa1009638
EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, Schellong S (2010) Oral rivaroxaban for symptomatic venous thromboembolism. New Engl J Med 363(26):2499–2510. doi:10.1056/NEJMoa1007903
EINSTEIN-PE Investigators, Buller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, Minar E, Chlumsky J, Verhamme P, Wells P, Agnelli G, Cohen A, Berkowitz SD, Bounameaux H, Davidson BL, Misselwitz F, Gallus AS, Raskob GE, Schellong S, Segers A (2012) Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. New Engl J Med 366(14):1287–1297. doi:10.1056/NEJMoa1113572
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vandenbriele, C., Vanassche, T., Peetermans, M. et al. Rivaroxaban for the treatment of consumptive coagulopathy associated with a vascular malformation. J Thromb Thrombolysis 38, 121–123 (2014). https://doi.org/10.1007/s11239-013-1024-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-013-1024-7